Edition:
United States

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

4.23USD
27 Sep 2016
Change (% chg)

-- (--)
Prev Close
$4.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
555,246
52-wk High
$18.62
52-wk Low
$2.96

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.33 December 28 Sep 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 4 4 4
(3) HOLD 4 4 4 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.20 2.20 2.27

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 7 0.79 1.40 0.00 0.44
Quarter Ending Dec-16 7 0.81 1.40 0.00 0.44
Year Ending Dec-16 8 4.20 5.50 2.70 3.88
Year Ending Dec-17 8 16.00 102.50 1.00 147.04
Earnings (per share)
Quarter Ending Sep-16 9 -0.33 -0.29 -0.36 -0.37
Quarter Ending Dec-16 9 -0.34 -0.29 -0.37 -0.40
Year Ending Dec-16 9 -1.34 -1.25 -1.40 -1.40
Year Ending Dec-17 9 -1.23 -0.46 -1.54 -0.66

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 0.85 1.39 0.54 63.41
Quarter Ending Mar-16 0.86 1.30 0.45 52.04
Quarter Ending Dec-15 0.70 1.79 1.09 155.20
Quarter Ending Sep-15 0.78 1.03 0.25 31.69
Quarter Ending Jun-15 0.45 2.18 1.73 388.67
Earnings (per share)
Quarter Ending Jun-16 -0.34 -0.32 0.02 -4.96
Quarter Ending Mar-16 -0.35 -0.35 0.00 -0.29
Quarter Ending Dec-15 -0.35 -0.33 0.02 -4.82
Quarter Ending Sep-15 -0.35 -0.32 0.03 -8.28
Quarter Ending Jun-15 -0.34 -0.33 0.01 -2.94

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 0.79 0.79 0.80 0.85 0.44
Quarter Ending Dec-16 0.81 0.81 0.81 0.88 0.44
Year Ending Dec-16 4.20 4.20 4.20 3.84 3.88
Year Ending Dec-17 16.00 16.00 16.00 15.96 147.04
Earnings (per share)
Quarter Ending Sep-16 -0.33 -0.33 -0.33 -0.34 -0.37
Quarter Ending Dec-16 -0.34 -0.34 -0.34 -0.34 -0.40
Year Ending Dec-16 -1.34 -1.34 -1.34 -1.36 -1.40
Year Ending Dec-17 -1.23 -1.23 -1.23 -1.26 -0.66

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.